Fundraising Fox
Briteseed
Chicago, US · Founded 2013 · 14 employees on LinkedIn · 4 known investors
Find your way into Briteseed
Sign up to see every warm intro you have to Briteseed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Briteseed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Briteseed develops hyperspectral imaging technology integrated into laparoscopic and robotic surgical instruments to provide real-time visualization of critical anatomical structures during surgery. The company produces a suite of surgical tools including energy, stapler, and dissection instruments that display information on existing operating room monitors to improve surgical safety and outcomes.
Founders & leadership
Briteseed was founded in 2013 by Jonathan Whitney Gunn.
Investors · 4
How we know: GOOSE Capital's portfolio page · Not right? Tell us
How we know: TMC Venture Fund's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$690K disclosed across 1 round · 2013
▶$690KraisedJan 2014 · 15 investors · Other Health Care
- Paul Albert FehrenbacherExecutive Officer, Director
- Jonathan Whitney GunnExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $690K
- Minimum investment
- $25K
- First sale
- Apr 2013
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 05
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $497.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.4M |
| National Science Foundation | Phase II | 2017 | $750K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $274.9K |
| National Science Foundation | Phase I | 2015 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Briteseed do?
- Briteseed develops hyperspectral imaging technology integrated into laparoscopic and robotic surgical instruments to provide real-time visualization of critical anatomical structures during surgery. The company produces a suite of surgical tools including energy, stapler, and dissection instruments that display information on existing operating room monitors to improve surgical safety and outcomes.
- Who founded Briteseed?
- Briteseed was founded by Jonathan Whitney Gunn in 2013.
- Who are Briteseed's investors?
- Briteseed's investors include GOOSE Capital, TMC Venture Fund, Hyde Park Angels, Lightbank.
- How much funding has Briteseed raised?
- Briteseed has disclosed $690K raised across 1 round.
- Where is Briteseed headquartered?
- Briteseed is headquartered in Chicago, US.